AI heart monitor study for ejection fraction
Part of Brain & nervous system, Genetic & congenital, Heart & circulation, Injuries & trauma clinical trials.
This study uses an AI-powered wearable monitor to check how well your heart pumps blood (ejection fraction) from a simple EKG recording. It may help doctors quickly assess heart function without extra tests.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must be able and willing to wear a Holter monitor (a small device that records your heart's rhythm).
- You cannot be on a breathing machine, heart pump, or kidney dialysis at the time of the study.
- You cannot have a history of severe skin reactions to the sticky pads used for ECG monitoring.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an AI-powered wearable patch (the COR ECG) to see if it can better track heart and lung health. It may help doctors find problems earlier without needing bulky equipment.
This study tests whether artificial intelligence (AI) can analyze heart signals from a standard 12-lead ECG and a simpler 1-lead ECG. Participants will have an extra ECG taken during their regular visit, which takes just a few extra minutes and helps doctors learn if AI can spot heart issues from a simpler test.
This study uses artificial intelligence to analyze heart tests (ECGs) to help diagnose and predict outcomes for people with heart disease. It may lead to better and faster detection of heart conditions.
This study tests whether an AI-powered single-lead ECG (a simple heart tracing) can help detect narrowed coronary arteries. If successful, it could offer a simpler way to screen for heart disease.
This trial uses an AI tool to analyze your ECG (heart tracing) to detect low pumping function. It may help find hidden heart issues early, especially if you haven't had a recent heart ultrasound.
This trial uses an artificial intelligence system to analyze electrocardiograms (ECGs, which are recordings of your heart's electrical activity) to detect heart failure early. It is for people over 65 who either have symptoms that might be heart failure or have risk factors for heart failure but no current symptoms.
Hear when a new LV Dysfunction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.